GHRP-2 Dosage: How Much to Take, When & How
Overview
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic peptide that stimulates your body's natural growth hormone production by acting as a ghrelin receptor agonist. Unlike direct HGH injection, GHRP-2 works through your pituitary gland to trigger endogenous GH release, making it popular in research and performance contexts for body composition, recovery, and anti-aging support.
The standard dosing range is 100–300 mcg administered 2–3 times daily via subcutaneous injection, though optimal doses vary based on individual goals, experience level, and concurrent peptide stacking. This guide provides practical, evidence-based dosing protocols to help you determine the right amount for your situation.
Cost: Expect $30–$90 per month depending on dosing frequency and supplier.
Standard Dosing Protocol
The most commonly reported dosing framework for GHRP-2 is:
| Dose Level | Amount per Injection | Frequency | Total Daily Dose | Use Case |
|---|---|---|---|---|
| Low | 100 mcg | 1–2x daily | 100–200 mcg | Beginner, sensitivity testing, minimal side effects |
| Moderate | 150–200 mcg | 2–3x daily | 300–600 mcg | Standard protocol, balanced results & tolerability |
| High | 250–300 mcg | 2–3x daily | 500–900 mcg | Advanced users, experienced with peptides, maximum GH stimulus |
Key dosing facts from research:
- GHRP-2 increases GH secretion 4.8-fold more potently than GHRH alone in elderly men, demonstrating robust dose-response efficacy
- Doses in the 100–300 mcg range reliably trigger pulsatile GH release without excessive side effects in most users
- Splitting doses across 2–3 administrations per day maintains more stable GH signaling than single daily injections
Practical recommendation for most users: Start at 100–150 mcg once or twice daily (100–300 mcg total), assess tolerance for 5–7 days, then increase to 150–200 mcg twice daily (300–400 mcg total) as tolerated.
Dosing by Goal
Different goals may justify different dosing strategies:
Body Composition & Fat Loss
- Recommended dose: 150–200 mcg, 2x daily (300–400 mcg/day)
- Rationale: This range provides measurable GH elevation without excessive appetite stimulation. Note that GHRP-2 increases food intake by 10.2% at low doses and up to 33.5% at high doses, which works against fat loss if calories aren't controlled.
- Timing: Administer 30–60 minutes before meals or during fasted periods to maximize GH signaling without compounding appetite effects
- Duration: 3–4 months minimum to observe body composition changes; longer protocols (6+ months) show better results
Muscle Growth & Strength
- Recommended dose: 200–300 mcg, 2–3x daily (400–900 mcg/day)
- Rationale: Higher doses maximize IGF-1 elevation and GH pulse amplitude. In hypogonadal men on concurrent testosterone therapy, GHRP-2 increased IGF-1 from 159.5 ng/mL to 239.0 ng/mL over 4 months—a ~50% elevation that supports muscle protein synthesis.
- Stacking consideration: GHRP-2 works synergistically with GHRH analogs (like sermorelin) to produce supraphysiological GH peaks; combining them amplifies muscle-building signaling
- Timing: Inject immediately post-workout or before training; pre-sleep injection (1–2 hours before bed) capitalizes on endogenous GH surge during sleep
- Duration: 4–6 months for meaningful hypertrophy; combine with progressive resistance training and adequate protein intake
Recovery & Anti-Aging
- Recommended dose: 100–150 mcg, 2x daily (200–300 mcg/day)
- Rationale: Moderate dosing supports GH and IGF-1 elevation for tissue repair and collagen turnover without excessive hunger or cortisol elevation
- Timing: Morning injection (upon waking) and evening injection (1–2 hours pre-sleep)
- Duration: 3–6 months; longer protocols show plateau effects, making cycling beneficial
Injury/Tendon Recovery
- Recommended dose: 150–200 mcg, 2–3x daily (300–600 mcg/day)
- Rationale: Animal models show GHRP-2 enhances tendon-bone healing, reduces M1 macrophage markers, and improves bone mineral density. Higher doses within this range support tissue remodeling
- Timing: Inject around physical therapy or rehabilitation sessions; 1–2 additional injections spread throughout the day
- Duration: 8–12 weeks for acute injury; longer for chronic conditions
How to Administer
Injection Method
- Route: Subcutaneous (SC) injection only; GHRP-2 is not suitable for oral, intranasal, or intravenous self-administration
- Needle size: 25–30 gauge, ½–⅝ inch length (appropriate for SC administration)
- Injection sites: Abdomen (most common), thigh, or back of arm; rotate sites daily to minimize irritation and localized swelling
- Reconstitution: GHRP-2 is typically supplied as a lyophilized powder; reconstitute with bacteriostatic water (0.9% sodium chloride + benzyl alcohol) at a ratio that achieves your target dose volume (e.g., 100 mcg/0.1 mL for ease of dosing)
- Storage: Keep reconstituted GHRP-2 refrigerated (2–8°C) and use within 20–30 days to preserve peptide integrity; store lyophilized powder in a cool, dry place for extended shelf life
Injection Technique
- Clean the injection site with an alcohol wipe; let dry for 5 seconds
- Draw the appropriate volume into a sterile syringe (mark the barrel at your target volume for consistency)
- Pinch the skin to elevate subcutaneous tissue; insert the needle at a 45° angle
- Inject slowly over 3–5 seconds; withdraw the needle and apply gentle pressure with a clean gauze pad
- Alternate injection sites to prevent lipohypertrophy (fatty lumps) and localized irritation
Injection timing tip: Inject GHRP-2 on an empty stomach or 30–60 minutes before meals for optimal GH stimulus; food intake, particularly carbohydrates and fats, blunts the GH response.
Cycling & Timing Protocols
On-Cycle Duration
- Standard cycle: 8–16 weeks of continuous dosing, followed by 2–4 weeks off
- Extended cycle: 16–24 weeks for advanced users seeking sustained IGF-1 elevation and body composition changes
- Ultra-extended protocol: 30-day continuous subcutaneous infusion (via pump) maintains pulsatile GH elevation >1.8-fold on days 14–30; however, this approach is impractical for most self-administering users and carries higher side-effect risk (cortisol, prolactin elevation)
Break Timing
- Minimum off-time: 2–4 weeks every 8–16 weeks to allow pituitary sensitivity to reset and reduce adaptation